FIKCX vs. JNGLX

Last updated Jun 25, 2026

FIKCX (Fidelity Advisor Health Care Fund Class Z) and JNGLX (Janus Henderson Global Life Sciences Fund) are both Health & Biotech Equities funds. Over the past 5 years, FIKCX returned 0.57%/yr vs 7.57%/yr for JNGLX. Their correlation of 0.93 suggests significant overlap in exposure. FIKCX charges 0.59%/yr vs 0.80%/yr for JNGLX.

Performance

FIKCX vs. JNGLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Advisor Health Care Fund Class Z (FIKCX) and Janus Henderson Global Life Sciences Fund (JNGLX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FIKCX achieves a 2.34% return, which is significantly lower than JNGLX's 3.72% return.

FIKCX

• 1D: 1.11%
• 1M: 5.64%
• YTD: 2.34%
• 6M: 0.56%
• 1Y: 22.05%
• 3Y*: 3.94%
• 5Y*: 0.57%
• 10Y*: —

JNGLX

• 1D: 1.23%
• 1M: 3.86%
• YTD: 3.72%
• 6M: 2.71%
• 1Y: 33.05%
• 3Y*: 11.75%
• 5Y*: 7.57%
• 10Y*: 11.83%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FIKCX vs. JNGLX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
FIKCX Fidelity Advisor Health Care Fund Class Z	2.34%	14.61%	-5.73%	4.20%	-12.74%	11.66%	21.55%	28.39%	-11.04%
JNGLX Janus Henderson Global Life Sciences Fund	3.72%	24.84%	3.60%	7.51%	-2.69%	6.78%	25.66%	29.20%	-9.45%

Correlation

The correlation between FIKCX and JNGLX is 0.90, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.90
Correlation (3Y) Calculated over the trailing 3-year period	0.90
Correlation (5Y) Calculated over the trailing 5-year period	0.93
Correlation (All Time) Calculated using the full available price history since Oct 17, 2018	0.93

The correlation between FIKCX and JNGLX has been stable across timeframes, ranging from 0.90 to 0.93 - a consistent structural relationship.

Return for Risk

FIKCX vs. JNGLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FIKCX

FIKCX Risk / Return Rank: 30
FIKCX Sharpe Ratio Rank: 33
FIKCX Sortino Ratio Rank: 36
FIKCX Omega Ratio Rank: 29
FIKCX Calmar Ratio Rank: 29
FIKCX Martin Ratio Rank: 22

JNGLX

JNGLX Risk / Return Rank: 73
JNGLX Sharpe Ratio Rank: 75
JNGLX Sortino Ratio Rank: 77
JNGLX Omega Ratio Rank: 64
JNGLX Calmar Ratio Rank: 83
JNGLX Martin Ratio Rank: 64

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FIKCX vs. JNGLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Health Care Fund Class Z (FIKCX) and Janus Henderson Global Life Sciences Fund (JNGLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FIKCX	JNGLX	Difference
Sharpe ratio: Return per unit of total volatility	1.47	2.30	-0.83
Sortino ratio: Return per unit of downside risk	2.22	3.33	-1.11
Omega ratio: Gain probability vs. loss probability	1.25	1.40	-0.15
Calmar ratio: Return relative to maximum drawdown	1.81	3.63	-1.82
Martin ratio: Return relative to average drawdown	4.77	11.57	-6.80

FIKCX vs. JNGLX - Sharpe Ratio Comparison

The current FIKCX Sharpe Ratio is 1.47, which is lower than the JNGLX Sharpe Ratio of 2.30. The chart below compares the historical Sharpe Ratios of FIKCX and JNGLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FIKCX vs. JNGLX - Drawdown Comparison

The maximum FIKCX drawdown since its inception was -29.19%, smaller than the maximum JNGLX drawdown of -59.00%. Use the drawdown chart below to compare losses from any high point for FIKCX and JNGLX.

Drawdown Indicators

	FIKCX	JNGLX	Difference
Max Drawdown Largest peak-to-trough decline	-29.19%	-59.00%	+29.81%
Max Drawdown (1Y) Largest decline over 1 year	-13.35%	-9.68%	-3.67%
Max Drawdown (3Y) Largest decline over 3 years	-25.31%	-21.17%	-4.14%
Max Drawdown (5Y) Largest decline over 5 years	-29.19%	-22.21%	-6.98%
Max Drawdown (10Y) Largest decline over 10 years	—	-27.37%	—
Current Drawdown Current decline from peak	-3.94%	0.00%	-3.94%
Average Drawdown Average peak-to-trough decline	-9.25%	-17.62%	+8.37%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.05%	3.03%	+2.02%

Volatility

FIKCX vs. JNGLX - Volatility Comparison

Fidelity Advisor Health Care Fund Class Z (FIKCX) and Janus Henderson Global Life Sciences Fund (JNGLX) have volatilities of 5.91% and 5.68%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FIKCX	JNGLX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.91%	5.68%	+0.23%
Volatility (6M) Calculated over the trailing 6-month period	12.72%	11.44%	+1.28%
Volatility (1Y) Calculated over the trailing 1-year period	16.45%	15.27%	+1.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.47%	15.94%	+2.53%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	20.29%	17.36%	+2.93%

FIKCX vs. JNGLX - Expense Ratio Comparison

FIKCX has a 0.59% expense ratio, which is lower than JNGLX's 0.80% expense ratio.

Dividends

FIKCX vs. JNGLX - Dividend Comparison

FIKCX's dividend yield for the trailing twelve months is around 11.22%, more than JNGLX's 4.40% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FIKCX Fidelity Advisor Health Care Fund Class Z	11.22%	11.48%	0.00%	0.00%	0.00%	5.71%	5.86%	0.61%	4.65%	0.00%	0.00%	0.00%
JNGLX Janus Henderson Global Life Sciences Fund	4.40%	4.56%	5.84%	4.26%	0.25%	9.85%	7.80%	6.23%	13.32%	0.89%	0.30%	8.81%

Frequently Asked Questions

Can I hold both FIKCX and JNGLX in my portfolio?

With a correlation of 0.90, FIKCX and JNGLX move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

Which is riskier, FIKCX or JNGLX?

FIKCX has higher volatility (5.91%) compared to JNGLX (5.68%). In terms of maximum drawdown, FIKCX dropped -29.19% vs JNGLX's -59.00%.

Which has better risk-adjusted returns?

JNGLX currently has the higher Sharpe Ratio (2.30 vs 1.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.